A new research paper titled "Inhibiting BRAF/EGFR/MEK suppresses cancer stemness and drug resistance of primary colorectal cancer cells" has been published in Oncotarget.
Oct 11, 2023
0
0
A new editorial perspective was published in Oncotarget, titled "STAT3 as a biologically relevant target in H3K27M-mutant diffuse midline glioma."
Oct 10, 2023
0
1
New research by RMIT University and Northern Health has examined Australia's long COVID services, guidelines and public health information, compared with international standards.
Oct 5, 2023
0
23
An oral lipid nanoparticle drug prevents tumor development in mice, suggesting this is a promising drug formulation for preventing colitis-associated cancer, according to a study led by researchers in the Institute for Biomedical ...
Oct 3, 2023
0
43
Using zebrafish as a model, investigators have determined a suitable combination of chemical compounds in which to store hearts, and potentially other organs, when frozen for extended periods of time before transplantation.
Oct 2, 2023
0
7
Clinicians treating severe obesity have a new genetic tool for predicting—and ultimately improving—bariatric surgery outcomes.
Sep 28, 2023
0
2
A new editorial paper titled "Reassessing the risks and benefits of COVID-19 precautions in 2023" has been published in Oncotarget.
Sep 28, 2023
0
0
E. coli is a well-known risk factor in food preparation and hygiene, but how does it cause damage in the body and how does an outbreak have the power to send hundreds to hospital, potentially with kidney damage?
Sep 18, 2023
0
6
A new editorial paper titled "Systemic treatment for brain metastasis in HER2- positive advanced breast cancer: what have we learned so far?" has been published in Oncotarget.
Sep 13, 2023
0
1
A new editorial paper titled "Latest updates on MET targeted therapy for EXON 14 mutations in lung cancer" has been published in Oncotarget.
Sep 11, 2023
0
13
